Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Celia Moises"'
Autor:
Brady Beltrán Gárate, Gadwyn Sánchez Félix, Domingo Morales Luna, Giuliana Castro Vargas, Manuel Phillco Salas, Antonio Paredes Arcos, Karem Portugal Valdivia, Víctor Delgado González, Carlos Barrionuevo Cornejo, Francisco Bravo Puccio, Jorge Valdez Gómez, Celia Moises Alfaro, César Pérez del Arca, Rossina Arroyo Barrios
Publikováno v:
Acta Médica Peruana, Vol 26, Iss 3 (2009)
Introducción: varias revisiones y guías de manejo de Micosis Fungoides (MF) y Síndrome Sézary(SS) han sido publicados. Sin embargo, estrategias terapeúticas para esta entidad varían entre instituciones y países. Existen pocos estudios fase III
Externí odkaz:
https://doaj.org/article/4f7b1f89aa4a4377a85336dea72b8c8e
Autor:
Ursula Aviles-Perez, Gustavo Sandival-Ampuero, Jorge J. Castillo, Luis Malpica Castillo, Cristaldo Nancy, Mirna Churin, Kelly Meza, Pablo Soto, Luis Villela, Antonio Paredes, Henry Idrobo, Fabiola Valvert, Juan L. Maradei, Luciana Guanchiale, Eloisa Riva, Laura Aguirre-Martinez, Celia Moises, Eduardo M. Sotomayor, Maria Elena Cabrera, Myrna Candelaria, Camila Peña, Bryan Valcarcel, Maria Virginia Prates, Victoria Otero, Juan Antonio Choque, Marcos Di Stefano, Lorena Fiad, Roberto Oviedo-Pecho, Juan Carlos Ramos, Marialejandra Torres Viera, Milagros Altamirano, Gadwyn Sánchez, Andrea Noboa, Guilherme Fleury Perini, Jose Luis Viñuela, Sally Rose Paredes, Denisse Castro, Brady E Beltran, Alana Von Glasenapp, Daniel J Enriquez
Publikováno v:
Blood. 136:20-23
INTRODUCTION: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive peripheral T-cell neoplasm caused by the Human T-cell Leukemia Virus Type 1 (HTLV-1). HTLV-1 infects up to 10 million people worldwide and is most endemic in Southwestern Japan, Wes
Autor:
Daniel J Enriquez, Maria Virginia Prates, Grupo de Estudio Latinoamericano de Linfoproliferativos, Jorge J. Castillo, Brady E Beltran, Juan Carlos Ramos, Luis Villela, Luis Malpica, Mirna Biglione, Gadwyn Sánchez, Celia Moises, Roberto Oviedo-Pecho, Bryan Valcarcel, Camila Peña, Denisse Castro, Antonio Paredes, Henry Idrobo, Lorena Fiad
Publikováno v:
Leukemialymphoma. 63(2)
Adult T-cell leukemia/lymphoma (ATLL) is a largely incurable disease. Cutaneous involvement is common and could be first symptom of the disease. We analyzed 169 patients with ATLL of whom 63 had cutaneous involvement. Cutaneous involvement was found
Autor:
Antonio Paredes, Jorge J. Castillo, Celia Moises, Roberto N. Miranda, Pilar Quiñones, Brady E Beltran, Carlos A. Torres-Cabala, Gadwyn Sánchez, Esther Cotrina
Publikováno v:
Leukemia & Lymphoma. 59:1753-1755
Plasmablastic lymphoma (PBL) is a distinct clinicopathological entity of large, mature B-lymphocytes, closely related to diffuse large B-cell lymphoma (DLBCL) [1–3], but also distinct because of it...
Autor:
Rodolfo Rodríguez-Jurado, Luz Orozco-Covarrubias, Ramon Ruiz-Maldonado, Celia Moises, Lourdes Tamayo-Sanchez, Carola Duran-Mckinster
Publikováno v:
Pediatric dermatology. 19(5)
Due to the presence of two different clones of cells in early embryogenesis, numerous congenital and acquired dermatoses have a linear distribution following the lines of Blaschko. Acquired inflammatory skin diseases are rarely observed in linear pat
Autor:
Antonio Paredes, Gadwin Sanchez, Jorge J. Castillo, Brady E Beltran, Celia Moises, Lubomir Sokol
Publikováno v:
Blood. 114:4790-4790
Abstract 4790 Introduction Selective ligands of retinoid X receptor (i.e. bexarotene) are used in the treatment of early and advanced stages of cutaneous T-cell lymphoma (CTCL). The objective of this study is to report a Peruvian single-institution e
Autor:
Brady E Beltran, Antonio Paredes, Gadwin Sanchez, Jorge J. Castillo, Renzo Salas, Fernando Hurtado, Celia Moises, Luis Riva
Publikováno v:
Blood. 112:5010-5010
Background: Selective ligands of retinoid X receptor (i.e. bexarotene) are used in the treatment of early and advanced stages of cutaneous T-cell lymphoma (CTCL). Relapsed or refractory cases of CTCL have poor prognosis and are in need of safe and mo
Autor:
Brady Beltrán Gárate, Antonio Paredes Arcos, Celia Moisés Alfaro, Gadwin Sanchez Félix, Luis Riva Gonzales, Fernando Hurtado de Mendoza, Esther Cotrina Montenegro, Renzo Salas Rojas
Publikováno v:
Acta Médica Peruana, Vol 25, Iss 4 (2018)
Introducción: bexaroteno es un rexinoide aprobado en el tratamiento de estadios tempranos y avanzados del linfoma cutáneo de células T (LCCT). Caso Clínico: el presente reporte de casos mostramos los resultados del empleo de bexaroteno en dosis b
Externí odkaz:
https://doaj.org/article/2f7fa752719e44429c345909d93a91cf